Abrilumab (AMG 181) in Adults With Moderate to Severe Crohn's Disease
Clinical trial NCT01696396 · COMPLETED
Trial details
- NCT number
- NCT01696396
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-04
- Primary completion
- 2014-12-26
- Enrollment
- 254
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.